
TY  - JOUR
TI  - Cell Biology/Immunology SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_4.x
DO  - doi:10.1111/j.1440-1843.2011.01937_4.x
SP  - 47
EP  - 50
PY  - 2011
ER  - 

TY  - JOUR
TI  - Cystic Fibrosis SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_7.x
DO  - doi:10.1111/j.1440-1843.2011.01937_7.x
SP  - 55
EP  - 58
PY  - 2011
ER  - 

TY  - JOUR
TI  - Asthma & Allergy SIG: Poster Session 1
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_1.x
DO  - doi:10.1111/j.1440-1843.2011.01937_1.x
SP  - 37
EP  - 39
PY  - 2011
ER  - 

TY  - JOUR
TI  - Lung Cancer SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_9.x
DO  - doi:10.1111/j.1440-1843.2011.01937_9.x
SP  - 62
EP  - 64
PY  - 2011
ER  - 

TY  - JOUR
TI  - Physiotherapy SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_14.x
DO  - doi:10.1111/j.1440-1843.2011.01937_14.x
SP  - 77
EP  - 80
PY  - 2011
ER  - 

TY  - JOUR
TI  - COPD SIG: Poster Session 1
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_5.x
DO  - doi:10.1111/j.1440-1843.2011.01937_5.x
SP  - 50
EP  - 52
PY  - 2011
ER  - 

TY  - JOUR
TI  - Respiratory Nurses SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_16.x
DO  - doi:10.1111/j.1440-1843.2011.01937_16.x
SP  - 85
EP  - 86
PY  - 2011
ER  - 

TY  - JOUR
TI  - COPD SIG: Poster Session 2
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_6.x
DO  - doi:10.1111/j.1440-1843.2011.01937_6.x
SP  - 53
EP  - 55
PY  - 2011
ER  - 

TY  - JOUR
TI  - Oeld/Population Health SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_10.x
DO  - doi:10.1111/j.1440-1843.2011.01937_10.x
SP  - 65
EP  - 66
PY  - 2011
ER  - 

TY  - JOUR
TI  - Asthma & Allergy SIG: Poster Session 3
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_3.x
DO  - doi:10.1111/j.1440-1843.2011.01937_3.x
SP  - 43
EP  - 46
PY  - 2011
ER  - 

TY  - JOUR
TI  - Respiratory Infectious Diseases SIG: Poster Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01937_15.x
DO  - doi:10.1111/j.1440-1843.2011.01937_15.x
SP  - 80
EP  - 84
PY  - 2011
ER  - 

TY  - JOUR
TI  - Key Words Index
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12386
DO  - doi:10.1111/jgh.12386
SP  - 956
EP  - 982
PY  - 2013
ER  - 

TY  - JOUR
AU  - Rybczynska, Anna A.
AU  - Boersma, Hendrikus H.
AU  - de Jong, Steven
AU  - Gietema, Jourik A.
AU  - Noordzij, Walter
AU  - Dierckx, Rudi A. J. O.
AU  - Elsinga, Philip H.
AU  - van Waarde, Aren
TI  - Avenues to molecular imaging of dying cells: Focus on cancer
JO  - Medicinal Research Reviews
JA  - Med Res Rev
VL  - 38
IS  - 6
SN  - 0198-6325
UR  - https://doi.org/10.1002/med.21495
DO  - doi:10.1002/med.21495
SP  - 1713
EP  - 1768
KW  - apoptosis
KW  - early treatment response
KW  - necrosis
KW  - positron emission tomography (PET)
KW  - single photon emission computed tomography (SPECT)
PY  - 2018
AB  - Abstract Successful treatment of cancer patients requires balancing of the dose, timing, and type of therapeutic regimen. Detection of increased cell death may serve as a predictor of the eventual therapeutic success. Imaging of cell death may thus lead to early identification of treatment responders and nonresponders, and to ?patient-tailored therapy.? Cell death in organs and tissues of the human body can be visualized, using positron emission tomography or single-photon emission computed tomography, although unsolved problems remain concerning target selection, tracer pharmacokinetics, target-to-nontarget ratio, and spatial and temporal resolution of the scans. Phosphatidylserine exposure by dying cells has been the most extensively studied imaging target. However, visualization of this process with radiolabeled Annexin A5 has not become routine in the clinical setting. Classification of death modes is no longer based only on cell morphology but also on biochemistry, and apoptosis is no longer found to be the preponderant mechanism of cell death after antitumor therapy, as was earlier believed. These conceptual changes have affected radiochemical efforts. Novel probes targeting changes in membrane permeability, cytoplasmic pH, mitochondrial membrane potential, or caspase activation have recently been explored. In this review, we discuss molecular changes in tumors which can be targeted to visualize cell death and we propose promising biomarkers for future exploration.
ER  - 

TY  - JOUR
TI  - 2015 BioIron Meeting Abstracts
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 91
IS  - 3
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.24277
DO  - doi:10.1002/ajh.24277
SP  - E20
EP  - E266
PY  - 2016
ER  - 

TY  - JOUR
TI  - Scientific Program
JO  - American Journal of Transplantation
VL  - 8
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2008.02253.x
DO  - doi:10.1111/j.1600-6143.2008.02253.x
SP  - 57
EP  - 176
PY  - 2008
ER  - 

TY  - JOUR
TI  - Posters
JO  - Vox Sanguinis
VL  - 101
IS  - s2
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2011.01546.x
DO  - doi:10.1111/j.1423-0410.2011.01546.x
SP  - 39
EP  - 134
PY  - 2011
ER  - 

AU  - Steinhoff, M.
AU  - Groves, R. W.
AU  - LeBoit, P. E.
AU  - Luger, T. A.
C7  - pp. 1-76
TI  - Inflammation
SN  - 9781405161695
UR  - https://doi.org/10.1002/9781444317633.ch12
DO  - doi:10.1002/9781444317633.ch12
SP  - 1-76
KW  - defensins, alpha (TNF-α) and natural killer (NK), cytolytic factor
KW  - defensins - Human β-defensin-1
KW  - Mannose receptors and other C type lectins - mannosyl/fucosyl or GlcNAc-glycoconjugate ligands
KW  - cell apoptosis and inflammation - caspases, intracellular cysteine proteases with aspartate specificity
KW  - cell apoptosis and inflammation - death signal receptors and apical belbbing
KW  - cellular components of cutaneous inflammation - Kindler syndrome
KW  - Natural killer cells: NK cells
KW  - Natural killer cells - signalling lymphocytic activating molecule (SLAM)
KW  - basophils, chymase degrading neuropeptide neurotensin
KW  - monocytes and macrophages - antigen-presenting cells
PY  - 2011
AB  - Summary This chapter contains sections titled: Clinical characteristics of inflammation Phases of inflammation Innate defence mechanisms Cell apoptosis and inflammation Major histocompatibility complex and inflammation Cellular components of cutaneous inflammation Mediators of inflammation Vasculature and inflammation References
ER  - 

TY  - JOUR
TI  - 46th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 28
IS  - 3
SN  - 9781405161695
UR  - https://doi.org/10.1111/exd.13859
DO  - doi:10.1111/exd.13859
SP  - e1
EP  - e122
PY  - 2019
ER  - 

TY  - JOUR
TI  - Symposium Session Summaries
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 48
IS  - S36
SN  - 9781405161695
UR  - https://doi.org/10.1002/ppul.22896
DO  - doi:10.1002/ppul.22896
SP  - 103
EP  - 206
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 47
IS  - S35
SN  - 9781405161695
UR  - https://doi.org/10.1002/ppul.22682
DO  - doi:10.1002/ppul.22682
SP  - 223
EP  - 446
PY  - 2012
ER  - 
